Christopher B. Driscoll

Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

Laura Evgin, Tim Kottke, Jason M. Tonne et al. · Science Translational Medicine · 2022 · 202 citations · Full text

Medicine, Immunology, Oncology +17

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

Laura Evgin, Amanda L. Huff, Phonphimon Wongthida et al. · Nature Communications · 2020 · 118 citations · Full text

Medicine, Immunology, Oncology +17

APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy

Christopher B. Driscoll, Matthew Schuelke, Timothy Kottke et al. · Nature Communications · 2020 · 77 citations · Full text

Medicine, Immunology, Oncology +17

β-Glucan–Activated Human B Lymphocytes Participate in Innate Immune Responses by Releasing Proinflammatory Cytokines and Stimulating Neutrophil Chemotaxis

Mohamed F. Ali, Christopher B. Driscoll, P. Walters et al. · The Journal of Immunology · 2015 · 73 citations · Full text

Life Sciences, Immunology, Microbiology +17

Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategy

Honey V. Reddi, Christopher B. Driscoll, Pranathi Madde et al. · Cancer Gene Therapy · 2013 · 27 citations

Medicine, Molecular Biology, Oncology +17